High Court showdown for NICE decision

Drug manufacturers and campaign groups have been given the greenlight to take the government’s healthcare advisory body to court over its rulings concerning the withdrawal of dementia drug treatments. The decision marks the first time that the National Institute for Health and Clinical Excellence (NICE) has been held to a judicial review over one of…